Ravist Tablet
Tripotassium Bismuth Dicitrate · Ranitidine Hydrochloride +1 more
Prescription medication · Combination
IYUN Pharmaceuticals Co., Ltd.
MFDS item code 201906210 · Approved 2019.09.01
This product's status changed to Approval withdrawn on 2023.06.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (including ulcers and gastritis); prevention of Mendelson syndrome before anesthesia
This medication is used for diseases of the digestive organs, such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective for rare acid secretion disorders such as Zollinger-Ellison syndrome. It is used to prevent ulcers that may occur post-surgery and to prevent Mendelson's syndrome through pre-anesthetic dosing. It is used to treat gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication helps protect the gastric mucosa by regulating gastric acid secretion and improving symptoms.
○ Adults Usually, take 1 tablet orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer for some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 1 tablet 2 hours before induction of anesthesia. It is also preferable to take 1 tablet on the night before surgery.
This medication should not be used in patients undergoing dialysis treatment. Patients who have had allergic reactions to this drug or its components should not take it. Patients with acute porphyria, a rare disease, should be cautious as this medication can trigger seizures. Patients with renal impairment or kidney disorders should avoid using this medication. This drug should not be administered to patients who have undergone gastrointestinal surgery. Pregnant women or those who may become pregnant should not take this medication, and it is also not safe for premature infants and newborns. Patients following a diet that restricts potassium intake should also avoid this medication. Patients with poor liver function or a history of drug allergies should use this medication cautiously. Elderly patients or those with a history of kidney disorders should be careful when taking this drug, especially when used in conjunction with NSAIDs. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or those who have recently developed dyspeptic symptoms over the age of middle age should confirm malignancy status before use. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should undergo eradication therapy concurrently. In critically ill patients in intensive care units, there have been reports of gastric stone formation, so caution is needed. Patients with hypophosphatemia should be cautious as the aluminum component in this medication may interfere with phosphate absorption. In patients with difficulty swallowing, there is a risk of respiratory complications, so use with caution. During the course of taking this medication, rare occurrences of allergic reactions such as anaphylactic shock, skin rashes, hives, fever, and bronchospasm may occur, so if any unusual symptoms arise, discontinuation is advised. Blood tests may show decreased white blood cells or platelets, so symptoms such as fatigue, bleeding, and fever should be reported to a physician. Liver function impairment may occur, so if symptoms of jaundice or fatigue arise, immediate medical attention is necessary. Cardiac arrhythmias have been rarely reported, so patients with heart disease should be cautious. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and stools may become dark but typically do not require special treatment. Neurological symptoms such as dizziness, drowsiness, confusion, headache, and insomnia may occur occasionally, so it is advisable to avoid driving or operating dangerous machinery. Gynecomastia and erectile dysfunction have been very rarely reported, but causality is unclear. Muscle pain or joint pain could occur, and if there are severe muscle damage symptoms, discontinue use immediately. Skin rashes or hair loss may occur infrequently. Avoid long-term use of this medication, and if treatment effects are absent, it should be switched to another drug. Elderly individuals or patients with chronic lung disease or diabetes may have an increased risk of pneumonia, so caution is warranted. If dizziness or drowsiness occurs after taking this medication, it is safest to refrain from driving or engaging in hazardous work. This medication may interact with other drugs, especially anticoagulants or specific antibiotics, so consult a physician or pharmacist when taking these concurrent. It is safest for pregnant or breastfeeding women to avoid this medication, and safety in pediatric patients has not been established, hence it is not recommended for use. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and blood dialysis may be performed if needed. This medication reduces gastric acid secretion, which may promote bacterial colonization in the stomach, so long-term administration may require regular examinations, including eye check-ups.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to protect it from air and moisture. The storage temperature should be kept at room temperature between 1 degree and 30 degrees Celsius.
Pale green rectangular film-coated tablet
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate · Ranitidine Hydrochloride +1 more
Prescription medication · Combination
IYUN Pharmaceuticals Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.